Thu, Jan 17, 2019
FMCG major HUL on Thursday said it expects the merger of GlaxoSmithKline Consumer Healthcare (GSKCH India) through an-all equity deal to complete in six-nine months due to pending clearances from various authorities.
More >
HUL Q3 results: Transaction of this deal is an all-equity merger with 4.39 shares of HUL being allotted for every share in GSK CH India.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
